[ad_1]
“The saliva was vaccinated yesterday with the Oxford / AstraZeneca vaccine, which was found to be safe and effective,” Numa wrote in a post.
According to her, the day after the vaccination N. Numa feels very well, there are no side effects, the temperature is normal, the hand is not swollen.
“Nerijus thanks Sophie, who vaccinated him very quickly and professionally. When asked what to do for those who have the opportunity to get vaccinated, but hesitating, Nerijus replies that he himself was excited to get vaccinated at the first opportunity, and just after the vaccination he knew which vaccine he had received.
Thus it coincided that Nerius reached the middle of the vaccine queue, since yesterday it was announced that the United Kingdom had already vaccinated more than half of the adult population, about 27 million. people. Until then, he patiently and honestly awaited his turn in this universal free population vaccination program, and I signed him up for vaccination this week after he began vaccinating the population over 50, ”wrote K. Numa.
In Lithuania and the European Union, vaccination with AstraZeneca has been suspended due to identified cases of thromboembolism in vaccinated people.
On Thursday, the European Medicines Agency announced that this vaccine against COVID-19 is safe and effective, so vaccination with this vaccine has been renewed in Lithuania.
The Health Minister announced this Thursday that the list of priority groups for vaccination against COVID-19 will be complemented by the country’s leaders, members of the Seimas and the Government.
To show confidence in the AstraZeneca vaccine, Prime Minister Ingrida Šimonytė will be vaccinated against COVID-19 on Monday morning, the Government Chancellery announced on Friday.
President Gitanas Nausėda, Seimas President Viktorija Čmilytė-Nielsen and Health Minister Arūnas Dulkys also plan to vaccinate with the AstraZeneca vaccine on Monday. They are vaccinated to increase confidence in this vaccine.
It is strictly forbidden to use the information published by DELFI on other websites, in the media or elsewhere, or to distribute our material in any way without consent, and if consent has been obtained, it is necessary to indicate DELFI as the source .
[ad_2]
